AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 80 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,105,176 | +101853.5% | 2,453,221 | -34.3% | 0.00% | 0.0% |
| Q1 2023 | $1,084 | -23.1% | 3,736,483 | +19.3% | 0.00% | 0.0% |
| Q4 2022 | $1,409 | -99.7% | 3,131,479 | +284.4% | 0.00% | – |
| Q3 2022 | $429,000 | +62.5% | 814,672 | +56.1% | 0.00% | – |
| Q2 2022 | $264,000 | -72.9% | 521,915 | +23.1% | 0.00% | -100.0% |
| Q1 2022 | $975,000 | -10.2% | 423,914 | +85.4% | 0.00% | – |
| Q4 2021 | $1,086,000 | -74.5% | 228,682 | -57.3% | 0.00% | -100.0% |
| Q3 2021 | $4,255,000 | +12.5% | 535,222 | -1.5% | 0.00% | +50.0% |
| Q2 2021 | $3,781,000 | +28.6% | 543,185 | +46.4% | 0.00% | 0.0% |
| Q1 2021 | $2,939,000 | -18.7% | 371,136 | -19.2% | 0.00% | -33.3% |
| Q4 2020 | $3,614,000 | +836.3% | 459,158 | +742.3% | 0.00% | – |
| Q3 2020 | $386,000 | -77.3% | 54,511 | -70.3% | 0.00% | -100.0% |
| Q2 2020 | $1,697,000 | +2510.8% | 183,450 | +1216.6% | 0.00% | – |
| Q1 2020 | $65,000 | -87.5% | 13,934 | -81.6% | 0.00% | -100.0% |
| Q2 2019 | $520,000 | +344.4% | 75,884 | +422.7% | 0.00% | – |
| Q1 2019 | $117,000 | -25.0% | 14,518 | -30.5% | 0.00% | – |
| Q4 2018 | $156,000 | -96.9% | 20,884 | -95.6% | 0.00% | -100.0% |
| Q2 2018 | $5,041,000 | +584.9% | 476,478 | +542.2% | 0.01% | +600.0% |
| Q1 2018 | $736,000 | +881.3% | 74,190 | +436.5% | 0.00% | – |
| Q4 2017 | $75,000 | -67.4% | 13,829 | -61.5% | 0.00% | – |
| Q3 2016 | $230,000 | -24.3% | 35,955 | -42.6% | 0.00% | -100.0% |
| Q2 2016 | $304,000 | – | 62,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |